CANCERGUARD Trademark

Trademark Overview

On Tuesday, July 27, 2021, a trademark application was filed for CANCERGUARD with the United States Patent and Trademark Office. The USPTO has given the CANCERGUARD trademark a serial number of 90851355. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Exact Sciences Corporation. The CANCERGUARD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical laboratory services in the field of cancer; Laboratory services, namely, liquid biopsy services for scientific research purposes using laboratory developed tests in the field of medical and scientific research in the field of cancer; Providing laboratory research services in the field of gene expression
cancerguard

General Information

Serial Number90851355
Word MarkCANCERGUARD
Filing DateTuesday, July 27, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements

Description of MarkThe mark consists of the stylized mark CANCERGUARD.
Pseudo MarkCANCER GUARD
Goods and ServicesScientific and medical laboratory services in the field of cancer; Laboratory services, namely, liquid biopsy services for scientific research purposes using laboratory developed tests in the field of medical and scientific research in the field of cancer; Providing laboratory research services in the field of gene expression

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameExact Sciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMadison, WI 53719
Party NameExact Sciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMadison, WI 53719

Trademark Events

Event DateEvent Description
Friday, July 30, 2021NEW APPLICATION ENTERED
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 21, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, April 27, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 27, 2022SUSPENSION LETTER WRITTEN
Wednesday, November 30, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, June 13, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 16, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, January 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 1 GRANTED
Friday, September 20, 2024SOU EXTENSION 1 FILED

Related Keywords

cancerguard field services laboratory research scientific cancer medical providing tests developed